Abstract
Objective: To study the efficacy and practicality of treating headache in professional footballers with intranasal sumatriptan.
Methods: An open label drug trial was performed in elite Australian footballers using intranasal sumatriptan (20 mg) treatment for acute headache. The main outcome measures were treatment response at 30 minutes, two hours, and 24 hours using two criteria: (a) initial severity moderate or severe to nil or mild; (b) stricter criteria of initial severity moderate to severe to subsequent nil headache.
Results: Thirty eight attacks were analysed. The two hour response showed that 86% of attacks of migraine with aura and all of the attacks of migraine without aura responded to treatment with sumatriptan nasal spray. Complete relief of headache at two hours was reported by 71% of players with migraine with aura and 90% of those without aura. Recurrence rates were generally low, with 0% of migraine headaches and 25% non-migraine attacks recurring at 24 hours. Minor side effects were reported in 28 attacks.
Conclusions: This pilot open label trial suggests that sumatriptan nasal spray may be a valuable, effective, and convenient treatment of headache in professional sport. There are potential risks of this drug that need to be considered.
Full Text
The Full Text of this article is available as a PDF (49.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dahlöf C. G., Mathew N. Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern? Cephalalgia. 1998 Oct;18(8):539–545. doi: 10.1046/j.1468-2982.1998.1808539.x. [DOI] [PubMed] [Google Scholar]
- Diamond S., Elkind A., Jackson R. T., Ryan R., DeBussey S., Asgharnejad M. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine. Arch Fam Med. 1998 May-Jun;7(3):234–240. doi: 10.1001/archfami.7.3.234. [DOI] [PubMed] [Google Scholar]
- Hillis W. S., MacIntyre P. D. Sumatriptan and chest pain. Lancet. 1993 Jun 19;341(8860):1564–1565. doi: 10.1016/0140-6736(93)90700-q. [DOI] [PubMed] [Google Scholar]
- Matthews W. B. Footballer's migraine. Br Med J. 1972 May 6;2(5809):326–327. doi: 10.1136/bmj.2.5809.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCrory P. Headaches and exercise. Sports Med. 2000 Sep;30(3):221–229. doi: 10.2165/00007256-200030030-00006. [DOI] [PubMed] [Google Scholar]
- Rasmussen B. K. Epidemiology of headache. Cephalalgia. 1995 Feb;15(1):45–68. doi: 10.1046/j.1468-2982.1995.1501045.x. [DOI] [PubMed] [Google Scholar]
- Ryan R., Elkind A., Baker C. C., Mullican W., DeBussey S., Asgharnejad M. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Neurology. 1997 Nov;49(5):1225–1230. doi: 10.1212/wnl.49.5.1225. [DOI] [PubMed] [Google Scholar]
- Swain R. A., Kaplan B. Diagnosis, prophylaxis, and treatment of headaches in the athlete. South Med J. 1997 Sep;90(9):878–888. doi: 10.1097/00007611-199709000-00003. [DOI] [PubMed] [Google Scholar]
- Williams S. J., Nukada H. Sport and exercise headache: Part 1. Prevalence among university students. Br J Sports Med. 1994 Jun;28(2):90–95. doi: 10.1136/bjsm.28.2.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams S. J., Nukada H. Sport and exercise headache: Part 2. Diagnosis and classification. Br J Sports Med. 1994 Jun;28(2):96–100. doi: 10.1136/bjsm.28.2.96. [DOI] [PMC free article] [PubMed] [Google Scholar]